» Articles » PMID: 30187709

Bronchiectasis and Recurrent Respiratory Infections with a Gain-of-Function Variant: First Case in Korea

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2018 Sep 7
PMID 30187709
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Bronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation of the bronchi. Evaluation of underlying etiology is important in managing young bronchiectasis patients with recurrent infections caused by unusual pathogens. The signal transducer and activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for gain-of-function (GOF) alleles of the gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features, such as bronchiectasis. Here, we report on a patient with CMC and bronchiectasis with various types of infections who carried a pathogenic variant of the gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing revealed a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of from the patient and her parents revealed the patient had a occurrence of the variant. This is the first report of a Korean patient with a GOF pathogenic variant in . Physicians should be aware of the existence of this variant as a genetic factor associated with CMC and bronchiectasis complicated by recurrent infection.

Citing Articles

Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF.

Koh J, Kim D, Son S, Park H, Kim K, Min S J Clin Immunol. 2024; 44(4):84.

PMID: 38578320 PMC: 10997693. DOI: 10.1007/s10875-024-01687-9.


A child with bronchiectasis, chronic mucocutaneous candidiasis, and hypothyroidism secondary to STAT1 gain-of-function mutation: A case report and review of the literature.

Alidrisi D, Maksood L, Alqahtani W, Minshawi F, Aburziza A, Janem W Clin Case Rep. 2022; 10(4):e05791.

PMID: 35498362 PMC: 9040560. DOI: 10.1002/ccr3.5791.


Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova J J Clin Immunol. 2020; 40(8):1065-1081.

PMID: 32852681 PMC: 8561788. DOI: 10.1007/s10875-020-00847-x.


Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience.

Kwon W, Choi S, Kim H, Huh H, Kang J, Kim Y Allergy Asthma Immunol Res. 2020; 12(2):292-305.

PMID: 32009323 PMC: 6997278. DOI: 10.4168/aair.2020.12.2.292.


Impaired STAT3-Dependent Upregulation of IL2Rα in B Cells of a Patient With a STAT1 Gain-of-Function Mutation.

van Zelm M, Bosco J, Aui P, De Jong S, Hore-Lacy F, OHehir R Front Immunol. 2019; 10:768.

PMID: 31068927 PMC: 6491679. DOI: 10.3389/fimmu.2019.00768.

References
1.
Koo S, Kejariwal D, Al-Shehri T, Dhar A, Lilic D . Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation. United European Gastroenterol J. 2017; 5(5):625-631. PMC: 5548354. DOI: 10.1177/2050640616684404. View

2.
Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Becerra J . Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016; 127(25):3154-64. PMC: 4920021. DOI: 10.1182/blood-2015-11-679902. View

3.
Dotta L, Scomodon O, Padoan R, Timpano S, Plebani A, Soresina A . Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease. Clin Immunol. 2016; 164:1-9. DOI: 10.1016/j.clim.2015.12.010. View

4.
Araujo D, Shteinberg M, Aliberti S, Goeminne P, Hill A, Fardon T . Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J. 2017; 50(6). DOI: 10.1183/13993003.01289-2017. View

5.
Pasteur M, Bilton D, Hill A . British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010; 65 Suppl 1:i1-58. DOI: 10.1136/thx.2010.136119. View